Insider Buy/Sell Details for the Biotechnology Industry — Last 3 Months
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (3467)
MapLight Therapeutics, Inc. (MLPT)
Foff Erin Pennock — Chief Medical Officer
Shares
5,865
Price
$37.26
Total Value
$218.53K
Shares Held After
302,576
% of Holdings
1.9%
MapLight Therapeutics, Inc. (MLPT)
Foff Erin Pennock — Chief Medical Officer
Shares
9,163
Price
$36.46
Total Value
$334.08K
Shares Held After
308,441
% of Holdings
2.9%
MapLight Therapeutics, Inc. (MLPT)
Hanson Kristopher — General Counsel
Shares
11
Price
$37.96
Total Value
$417.56
Shares Held After
146,953
% of Holdings
0.0%
MapLight Therapeutics, Inc. (MLPT)
Hanson Kristopher — General Counsel
Shares
3,331
Price
$37.26
Total Value
$124.11K
Shares Held After
146,964
% of Holdings
2.2%
MapLight Therapeutics, Inc. (MLPT)
Hanson Kristopher — General Counsel
Shares
4,776
Price
$36.45
Total Value
$174.09K
Shares Held After
150,295
% of Holdings
3.1%
BeOne Medicines Ltd. (ONC)
OYLER JOHN — Director
Shares
520
Price
$323.59
Total Value
$168.26K
Shares Held After
0
% of Holdings
100.0%
BeOne Medicines Ltd. (ONC)
OYLER JOHN — Director
Shares
1,560
Price
$322.71
Total Value
$503.42K
Shares Held After
520
% of Holdings
75.0%
BeOne Medicines Ltd. (ONC)
OYLER JOHN — Director
Shares
13,109
Price
$321.61
Total Value
$4.22M
Shares Held After
2,080
% of Holdings
86.3%
BeOne Medicines Ltd. (ONC)
OYLER JOHN — Director
Shares
20,505
Price
$321.00
Total Value
$6.58M
Shares Held After
15,189
% of Holdings
57.4%
BeOne Medicines Ltd. (ONC)
OYLER JOHN — Director
Shares
15,097
Price
$319.99
Total Value
$4.83M
Shares Held After
35,694
% of Holdings
29.7%
BeOne Medicines Ltd. (ONC)
OYLER JOHN — Director
Shares
6,402
Price
$318.55
Total Value
$2.04M
Shares Held After
50,791
% of Holdings
11.2%
BeOne Medicines Ltd. (ONC)
OYLER JOHN — Director
Shares
42,798
Price
$317.79
Total Value
$13.60M
Shares Held After
57,193
% of Holdings
42.8%
BeOne Medicines Ltd. (ONC)
OYLER JOHN — Director
Shares
32,224
Price
$316.82
Total Value
$10.21M
Shares Held After
99,991
% of Holdings
24.4%
BeOne Medicines Ltd. (ONC)
OYLER JOHN — Director
Shares
19,752
Price
$316.00
Total Value
$6.24M
Shares Held After
132,215
% of Holdings
13.0%
BeOne Medicines Ltd. (ONC)
OYLER JOHN — Director
Shares
9,516
Price
$314.73
Total Value
$2.99M
Shares Held After
151,967
% of Holdings
5.9%
BeOne Medicines Ltd. (ONC)
OYLER JOHN — Director
Shares
4,881
Price
$314.08
Total Value
$1.53M
Shares Held After
161,483
% of Holdings
2.9%
BeOne Medicines Ltd. (ONC)
OYLER JOHN — Director
Shares
233
Price
$311.98
Total Value
$72.69K
Shares Held After
166,364
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
11
Price
$537.11
Total Value
$5.91K
Shares Held After
324,443
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
150
Price
$536.29
Total Value
$80.44K
Shares Held After
324,454
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
720
Price
$535.20
Total Value
$385.34K
Shares Held After
324,604
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,198
Price
$534.31
Total Value
$640.10K
Shares Held After
325,324
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
440
Price
$533.28
Total Value
$234.64K
Shares Held After
326,522
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
520
Price
$532.14
Total Value
$276.71K
Shares Held After
326,962
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,924
Price
$530.14
Total Value
$1.02M
Shares Held After
327,482
% of Holdings
0.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
3,057
Price
$529.46
Total Value
$1.62M
Shares Held After
329,406
% of Holdings
0.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,400
Price
$528.42
Total Value
$739.78K
Shares Held After
332,463
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
80
Price
$527.31
Total Value
$42.19K
Shares Held After
333,863
% of Holdings
0.0%
Monte Rosa Therapeutics, Inc. (GLUE)
Warmuth Markus — Director
Shares
9,500
Price
$23.18
Total Value
$220.22K
Shares Held After
585,038
% of Holdings
1.6%
Greenland Mines Ltd (GRML)
LeBlanc Jeff — Chief Financial Officer
Shares
1,400,000
Price
$0.18
Total Value
$245.28K
Shares Held After
4,820,342
% of Holdings
29.0%
InMed Pharmaceuticals Inc. (INM)
Vivo Opportunity, LLC — 10% Owner
Shares
2
Price
$1.55
Total Value
$3.10
Shares Held After
75,019
% of Holdings
0.0%
InMed Pharmaceuticals Inc. (INM)
Vivo Opportunity, LLC — 10% Owner
Shares
19
Price
$1.55
Total Value
$29.45
Shares Held After
743,057
% of Holdings
0.0%
Boundless Bio, Inc. (BOLD)
TANG KEVIN — 10% Owner
Shares
18,491
Price
$2.44
Total Value
$45.12K
Shares Held After
2,854,072
% of Holdings
0.6%
ADIAL PHARMACEUTICALS, INC. (ADIL)
Coastlands Capital LP — 10% Owner
Shares
1,233
Price
$2.75
Total Value
$3.39K
Shares Held After
388,308
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP&GENERAL COUNSEL
Shares
80
Price
$536.85
Total Value
$42.95K
Shares Held After
45,172
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP&GENERAL COUNSEL
Shares
1,519
Price
$534.99
Total Value
$812.65K
Shares Held After
45,252
% of Holdings
3.2%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP&GENERAL COUNSEL
Shares
1,041
Price
$535.88
Total Value
$557.85K
Shares Held After
46,771
% of Holdings
2.2%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP&GENERAL COUNSEL
Shares
3,279
Price
$534.21
Total Value
$1.75M
Shares Held After
47,812
% of Holdings
6.4%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP&GENERAL COUNSEL
Shares
800
Price
$532.94
Total Value
$426.35K
Shares Held After
51,091
% of Holdings
1.5%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP&GENERAL COUNSEL
Shares
861
Price
$531.97
Total Value
$458.03K
Shares Held After
51,891
% of Holdings
1.6%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP&GENERAL COUNSEL
Shares
120
Price
$529.81
Total Value
$63.58K
Shares Held After
52,752
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP&GENERAL COUNSEL
Shares
600
Price
$527.60
Total Value
$316.56K
Shares Held After
52,872
% of Holdings
1.1%
FORUM MARKETS Inc (FRMM)
Lomashuk Konstantin — 10% Owner
Shares
2,562
Price
$6.30
Total Value
$16.14K
Shares Held After
1,476,638
% of Holdings
0.2%
MapLight Therapeutics, Inc. (MLPT)
Kreitzer Anatol — Chief Discovery Officer
Shares
4,510
Price
$36.94
Total Value
$166.60K
Shares Held After
201,135
% of Holdings
2.2%
MapLight Therapeutics, Inc. (MLPT)
Kreitzer Anatol — Chief Discovery Officer
Shares
5,545
Price
$36.13
Total Value
$200.34K
Shares Held After
205,645
% of Holdings
2.6%
MapLight Therapeutics, Inc. (MLPT)
GILLIS JONATHAN — CAO and Interim CFO
Shares
4,699
Price
$36.94
Total Value
$173.58K
Shares Held After
171,164
% of Holdings
2.7%
MapLight Therapeutics, Inc. (MLPT)
GILLIS JONATHAN — CAO and Interim CFO
Shares
5,356
Price
$36.13
Total Value
$193.51K
Shares Held After
175,863
% of Holdings
3.0%
MapLight Therapeutics, Inc. (MLPT)
Kroeger Christopher A. — Director
Shares
90
Price
$37.54
Total Value
$3.38K
Shares Held After
1,332,316
% of Holdings
0.0%
MapLight Therapeutics, Inc. (MLPT)
Kroeger Christopher A. — Director
Shares
42,738
Price
$36.99
Total Value
$1.58M
Shares Held After
1,332,406
% of Holdings
3.1%
MapLight Therapeutics, Inc. (MLPT)
Kroeger Christopher A. — Director
Shares
18,950
Price
$36.00
Total Value
$682.20K
Shares Held After
1,375,144
% of Holdings
1.4%
MapLight Therapeutics, Inc. (MLPT)
Lillie James Woodruff — Chief Scientific Officer
Shares
12
Price
$37.54
Total Value
$450.48
Shares Held After
235,086
% of Holdings
0.0%
Showing 101–150 of 3467 transactions (page 3 of 70)